These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26331163)
1. [15-year experience of moxifloxacin in the treatment of patients with bacterial rhinosinusitis]. Ovchinnikov AY; Edzhe MA; Miroshnichenko NA; Hon EM; Korostelev SA Vestn Otorinolaringol; 2015; 80(3):75-79. PubMed ID: 26331163 [TBL] [Abstract][Full Text] [Related]
2. Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. Anon JB Clin Infect Dis; 2005 Jul; 41 Suppl 2(Suppl 2):S167-76. PubMed ID: 15942883 [TBL] [Abstract][Full Text] [Related]
3. Treatment of rhinosinusitis in the outpatient setting. Poole MD; Portugal LG Am J Med; 2005 Jul; 118 Suppl 7A():45S-50S. PubMed ID: 15993677 [TBL] [Abstract][Full Text] [Related]
5. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Anon JB Paediatr Drugs; 2003; 5 Suppl 1():25-33. PubMed ID: 14632103 [TBL] [Abstract][Full Text] [Related]
6. Rhinosinusitis: what is the desired outcome? Merenstein D Am Fam Physician; 2004 Nov; 70(9):1642, 1645. PubMed ID: 15554480 [No Abstract] [Full Text] [Related]
7. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis. Brook I Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313 [No Abstract] [Full Text] [Related]
8. Acute bacterial rhinosinusitis in adults: part II. Treatment. Scheid DC; Hamm RM Am Fam Physician; 2004 Nov; 70(9):1697-704. PubMed ID: 15554487 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431 [TBL] [Abstract][Full Text] [Related]
10. Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin. Sher LD; Poole MD; Von Seggern K; Wikler MA; Nicholson SC; Pankey GA Otolaryngol Head Neck Surg; 2002 Sep; 127(3):182-9. PubMed ID: 12297808 [TBL] [Abstract][Full Text] [Related]
12. Characterisation of patients receiving moxifloxacin for acute bacterial rhinosinusitis in clinical practice: results from an international, observational cohort study. Mösges R; Desrosiers M; Arvis P; Heldner S PLoS One; 2013; 8(4):e61927. PubMed ID: 23626752 [TBL] [Abstract][Full Text] [Related]
13. [Acute bacterial rhinosinusitis: current approaches to diagnosis and antibacterial therapy in out patient setting (recommendations of American Academy of otolaryngology, head and neck surgery, American Association of rhinologists, American Academy of ENT allergic diseases, 2000, Clinical consultative Committee for sinusitis in children and adults, 2000, American Academy of pediatrics, 2001, Center of disease and control, USA, 2001)]. Tarasov AA; Kamanin EI; Kriukov AI; Strachunskiĭ LS Vestn Otorinolaringol; 2003; (2):46-54. PubMed ID: 12958867 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Ferguson BJ; Guzzetta RV; Spector SL; Hadley JA Otolaryngol Head Neck Surg; 2004 Sep; 131(3):207-14. PubMed ID: 15365537 [TBL] [Abstract][Full Text] [Related]
18. Rhinosinusitis. An overview of current management measures in acute and chronic infection. Hadley JA Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):30-6. PubMed ID: 19667547 [TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of rhinosinusitis in children. Novembre E; Mori F; Pucci N; Bernardini R; Vierucci A; de Martino M Pediatr Allergy Immunol; 2007 Nov; 18 Suppl 18():56-61. PubMed ID: 17767611 [TBL] [Abstract][Full Text] [Related]
20. The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences. Young J; Bucher H; Tschudi P; Périat P; Hugenschmidt C; Welge-Lüssen A J Clin Epidemiol; 2003 Apr; 56(4):377-84. PubMed ID: 12767415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]